Carin Szostecki
- Molecular Biology top 10%
- Immunology top 10%
- Epidemiology top 10%
- Hepatology top 2%
- Rheumatology top 5%
- Co-authors
- Hans H. GuldnerHans WillHans NetterHelene WillThilo GrötzingerThomas SternsdorfMarcel KokenGustavo Linares‐Cruz
- Topics
- Liver Diseases and Immunity (7 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Retinoids in leukemia and cellular processes (5 papers)
- Cited by
- HepatologyHematologyImmunology
- Partner nations
- GermanyUnited StatesRussia
In The Last Decade
Carin Szostecki
16 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 917
- Immunology 400
- Epidemiology 396
- Hepatology 319
- Rheumatology 282
Countries citing papers authored by Carin Szostecki
This map shows the geographic impact of Carin Szostecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carin Szostecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carin Szostecki more than expected).
Fields of papers citing papers by Carin Szostecki
This network shows the impact of papers produced by Carin Szostecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carin Szostecki. The network helps show where Carin Szostecki may publish in the future.
Co-authorship network of co-authors of Carin Szostecki
This figure shows the co-authorship network connecting the top 25 collaborators of Carin Szostecki. A scholar is included among the top collaborators of Carin Szostecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carin Szostecki. Carin Szostecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 51 | |
| 4 | 67 | |
| 5 | 82 | |
| 6 | 21 | |
| 7 | 106 | |
| 8 | 422 | |
| 9 | [Humoral autoimmune response to nuclear Sp100 autoantigen in patients with primary biliary cirrhosis]. | 1 |
| 10 | 48 | |
| 11 | 142 | |
| 12 | 12 | |
| 13 | 52 | |
| 14 | 229 | |
| 15 | 70 | |
| 16 | 33 | |
| 17 | Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). | 86 |
| 18 | 118 |
About Carin Szostecki
Carin Szostecki is a scholar working on Hepatology, Gastroenterology and Rheumatology, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Retinoids in leukemia and cellular processes (5 papers). The work is most often cited by research in Hepatology (319 citations), Hematology (272 citations) and Immunology (400 citations). Carin Szostecki has collaborated with scholars based in Germany, United States and Russia. Frequent co-authors include Hans H. Guldner, Hans Will, Hans Netter, Helene Will, Thilo Grötzinger, Thomas Sternsdorf, Marcel Koken, Gustavo Linares‐Cruz, Fabien Calvo and Christine Chomienne. Their work appears in journals such as The Journal of Experimental Medicine, The EMBO Journal and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.